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We previously reported that a weak current (WC, 0.3-0.5mA/cm2) applied to 20 
cells can induce endocytosis to promote cytoplasmic delivery of hydrophilic 
macromolecules (MW: < 70,000), such as dextran and siRNA, which leak from WC-
induced endosomes into the cytoplasm (Hasan et al., 2016). In this study, we evaluated 
the characteristics of WC-mediated endocytosis for application of the technology to 
cytoplasmic delivery of macromolecular medicines. WC induced significantly higher 25 
cellular uptake of exogenous DNA fragments compared to untreated cells; the amount 
increased in a time-dependent manner, indicating that endocytosis was induced after WC. 
Moreover, following WC treatment of cells in the presence of an antibody (MW: 150,000) 
with the lysosomotropic agent chloroquine, the antibody was able to bind to its 
intracellular target. Thus, high molecular weight protein medicines delivered by WC-30 
mediated endocytosis were functional in the cytoplasm. Transmission electron 
microscopy of cells treated by WC in the presence of gold nanoparticles covered with 
polyethylene glycol showed that the WC-induced endosomes exhibited an elliptical shape. 
In the WC-induced endosomes, ceramide, which makes pore structures in the membrane, 
was localized. Together, these results suggest that WC can induce unique endocytosis and 35 
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Iontophoresis using weak current (WC; 0.3-0.5 mA/cm2) is a technology that 
promote permeation of ionized drug molecules for transdermal drug delivery (Kalia, et 
al., 2004; Karpiński, 2018). Electric repulsion and electro-osmosis are thought to be the 45 
primary mechanisms related to iontophoresis (Kalia, et al., 2004). Molecules that are 
amenable to iontophoresis are typically ionic, hydrophobic, and exhibit low molecular 
weights (<10,000). As such, iontophoresis was thought to be unsuitable to promote 
transdermal delivery of hydrophilic macromolecules such as proteins and nucleic acids. 
However, several groups reported the delivery of macromolecules, such as 50 
proteins and nucleic acids, by iontophoresis (Hashim, et al., 2010; Liu, et al., 2013; Patel, 
et al., 2013; Labala, et al., 2017). Hashim et al. succeeded in transdermal delivery of NF-
kB decoy oligonucleotides by iontophoresis, and suppression of tumor necrosis factor-a 
production (Hashim, et al., 2010). Liu, et al. reported the intradermal delivery of 
oligodeoxynucleotides by combination of a chemical penetration enhancer with 55 
iontophoresis (Liu, et al., 2013;). Patel, et al. delivered parvalbumin (MW: ca 12,000) 
across oral mucosa by iontophoresis (Patel, et al., 2013). Labala, et al. succeeded in the 
suppression of melanoma tumor by iontophoresis of signal transduction and activator of 
transcription factor 3 (STAT 3) and imatinib using gold nanoparticles (Labala, et al., 2017). 
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We previously demonstrated successful iontophoretic delivery of various nucleic 60 
acids, such as siRNA (MW: ca.12,000), CpG oligo DNA (MW: ca. 6,600), and liposomes 
encapsulating insulin into the skin (Kigasawa, et al., 2010; Kigasawa, et al., 2011, 
Kajimoto, et al., 2011) upon treatment with WC (0.3-0.5 mA/cm2). WC induced a 
decrease in the amount of the gap-junction protein connexin Cx43 and depolymerization 
of actin associated with tight-junction structures (Hama, et al., 2014). These findings 65 
indicate that the mechanism of skin penetration of hydrophilic macromolecules is via 
cleavage of intercellular junctions by WC (Hama, et al., 2014). 
 We also found that siRNA could be delivered by iontophoresis based on the 
successful knockdown of target mRNA in skin cells treated with WC (Kigasawa, et al., 
2010). This finding suggests that siRNA reaches the cytoplasm of WC-treated skin cells 70 
as RNAi reactions occur in the cytoplasmic space. We further found that WC-induced 
cellular uptake of siRNA is mediated by endocytosis (Hasan, et al., 2016a). In general, 
following endocytic cellular uptake, unmodified siRNA molecules (MW: ca. 12,000) 
cannot efficiently escape from conventional endosomes, such as clathrin-coated 
endosomes and macropinosomes, suggesting that cytoplasmic delivery of siRNA 75 
proceeds via an alternative mechanism. In our previous report, 10k FITC-dextran (MW: 
10,000) was widely dispersed in the cytoplasm 24 hr after treatment with WC, whereas 
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70k FITC-dextran (MW: 70,000) remained in the endosomes (Hasan, et al., 2016b). 
Together, these results suggest that WC-induced endosomes exhibit unique structural 
properties that allow for leakage of macromolecules having molecular weights <70,000. 80 
To better understand the characteristics of this unique WC-mediated endocytosis, 
we herein examined the temporal relationship between WC and cellular uptake, 
intracellular functionality of high molecular weight proteins delivered by WC, and 
morphological observation of WC-mediated endocytosis. We also sought to elucidate the 





2. Materials and methods 
2.1. Materials 
Cell lysis buffer and plasmid DNA encoding luciferase (pGL3-C) were purchased from 90 
Promega Corporation (Madison, WI). Ag-AgCl electrodes were purchased from 3M 
Health Care (Minneapolis, MN). Monoclonal anti-ceramide (mouse IgM isotype) was 
purchased from Sigma-Aldrich Co., Ltd. (St. Louis, MO). Mouse monoclonal antibody 
against anti-nuclear pore complex protein and goat anti-mouse IgG labeled with Alexa 
Fluor 488 were obtained from Abcam (Cambridge, UK). Chloroquine was purchased 95 
from Nakalai Tesque, Inc. (Kyoto, Japan). The mouse melanoma cell line B16-F1 was 
obtained from Dainippon Sumitomo Pharma Biomedical Co., Ltd. (Osaka, Japan). Cells 
were cultured in Dulbecco’s modified Eagle's medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) at 37 C in 5% CO2.  
 100 
2.2. Preparation of DNA fragments 
DNA fragments encoding the luciferase open reading frame region were prepared by PCR 
using pGL3-C as a template. The PCR primer sequences were: 5'-
CCGAAAGGTCTTACCGGAAAACTCG-3' and 5'-
TCCAAACTCATCAATGTATCTTATC-3'. PCR was performed using a PrimeScript One 105 
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Step RT-PCR Kit Ver. 2 (Takara Co. Ltd., Japan). The PCR products were subjected to 
15% agarose gel electrophoresis and the relevant DNA fragments were extracted from the 
agarose gel using NucleoSpin Gel and PCR Clean-up (Takara Co. Ltd., Japan). The DNA 
fragment concentration in the extracted solution was determined using a Nanodrop 
instrument (Thermo Fisher Scientific Inc., Waltham, MA). 110 
 
2.3. Weak current (WC) treatment of cultured cells 
B16-F1 cells (1x105 cells/well) were cultured in 35-mm dishes for WC treatment. After 
18 hr of cell culture, the cells were washed with PBS before 800 l serum-free DMEM 
containing DNA fragment (0.5 g) or antibody (6 g) was added to the cells. Ag-AgCl 115 
electrodes with a 2.5 cm2 surface area were placed in the dish, and the cells were treated 
with a constant WC of 0.34 mA/cm2 for 15 min.  
 
2.4. Quantification of DNA fragments in cells exposed to WC 
Following WC treatment with DNA fragments, B16-F1 cells were incubated at 37 C for 120 
1 hr or 3 hr and cellular DNA was extracted using a GenElute Mammalian Genomic DNA 
Miniprep Kit (Sigma-Aldrich, St. Louis, MO). The amount of DNA was quantified based 
on a calibration curve of the DNA fragment amplified using a real-time PCR Thermal 
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Cycler Dice Real Time System III (Takara Bio Inc., Japan).  
 125 
2.5. Immunostaining of cells following WC treatment in the presence of anti-nuclear 
pore complex antibody 
Following WC treatment (0.34 mA/cm2, 15 min), B16-F1 cells were incubated for 3 hr at 
37 C in the presence of anti-nuclear pore complex protein antibody and 0.01 mM 
chloroquine before 1 ml DMEM containing 10% FBS was added to the cell dish. After 130 
21 hr incubation, the cells were washed with PBS. Then, 0.5 ml of PBS containing 4% 
paraformaldehyde was added and the cells were incubated for 20 min at room temperature. 
The cells were washed with PBS containing 1% BSA and 0.1% Triton. After washing, the 
cells were incubated for an additional 20 min at room temperature in the presence of PBS 
containing 1% BSA and 0.1% Triton. Goat anti-mouse IgG labeled with Alexa Fluor 488 135 
(1 μg/mL in 1%BSA-0.1%Triton-PBS) was then added to the dish, and the cells were 
incubated for 60 min at room temperature. After incubation, the cells were washed three 
times with 1% BSA-0.1% Triton-PBS. Nuclei were stained by incubating the cells for 30 
min in the presence of DAPI solution (1 μg/mL in PBS) and the cells were washed with 





2.6. Transmission electron microscopic observation 
B16-F1 cells were treated with WC (0.34 mA/cm2) for 15 min in the presence of 
PEGylated gold nanoparticles having a diameter and zeta potential of 100 nm and -50 mV, 145 
respectively. Following WC treatment, cells were incubated for 4 hr; the culture medium 
was then removed and the cells were fixed with 2% paraformaldehyde (PFA) and 2% 
glutaraldehyde (GA) in 0.1 M phosphate buffer (PB) pH 7.4 at the incubation temperature, 
before subsequent incubation at 4 C. Thereafter, the cells were fixed with 2% GA in 0.1 
M PB at 4 C overnight. After fixation, the samples were washed 3 times with 0.1 M PB 150 
for 30 min per wash, and post-fixed with 2% osmium tetroxide (OsO4) in 0.1 M PB at 4 
C for 1 hr. The samples were dehydrated in graded ethanol solutions (50%, 70%, 90%, 
100%) by incubating for 5 min each in 50% and 70% solutions at 4 C, in 90% solution 
for 5 min at room temperature, and 3 changes of 100% ethanol for 5 min each at room 
temperature. The samples were transferred to Quetol-812 resin (Nisshin EM Co., Tokyo, 155 
Japan) and allowed to polymerize for 48 hr at 60 C. The polymerized resins were cut 
into ultra-thin, 90 nm sections with an ultramicrotome equipped with a diamond knife 
(Ultracut UCT; Leica, Vienna, Austria). The sections were mounted on copper grids that 
were stained with 2% uranyl acetate at room temperature for 15 min, and then washed 
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with distilled water followed by secondary staining with lead stain solution (Sigma-160 
Aldrich Co., Tokyo, Japan) at room temperature for 3 min. The grids were observed by 
transmission electron microscopy (JEM-1400Plus; JEOL Ltd., Tokyo, Japan) at an 
acceleration voltage of 80 kV. Digital images (2048 x 2048 pixels) were taken with a 
CCD camera (VELETA; Olympus Soft Imaging Solutions GmbH, Münster, Germany). 
 165 
2.7. Immunostaining of cells following WC treatment for detection of intracellular 
distribution of ceramide 
Following treatment with WC (0.34 mA/cm2, 15 min), B16-F1 cells were incubated for 
24 hr at 37 C. The cells were then washed with PBS. PBS (0.5 ml) containing 4% PFA 
was added and the cells were incubated for 20 min at 37 oC. The cells were washed three 170 
times with PBS containing 1% BSA and 0.1% Triton. After washing, the cells were 
incubated for an additional 20 min at 37 oC in the presence of PBS containing 1% BSA 
and 0.1% Triton. Then, the cells were washed with PBS containing 1% BSA. PBS 
containing 1% BSA and the primary antibody (mouse anti-ceramide IgM) was added to 
the cells, and the cells were incubated for 1 hr at 37 oC. Following that, the cells were 175 
washed three times with PBS containing 1% BSA. Goat anti-mouse IgG labeled with 
Alexa Fluor 488 in 1%BSA-0.1%Triton-PBS was then added to the dish, and the cells 
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were incubated for 1 hr at 37 oC. After incubation, the cells were washed three times with 
1% BSA-0.1% Triton-PBS. Nuclei were stained by incubating the cells for 30 min in the 
presence of DAPI solution, and the cells were washed with PBS before observation with 180 
an LSM700 confocal laser scanning microscope (Carl Zeiss, Germany). 
 
2.8. Immunohistochemical analysis of ceramide in skin cross sections after 
WC treatment 
The hair on the back skin of Balb/c mice was clipped, and treatment with WC 185 
(0.34 mA/cm2, 1 hr) was performed on the skin by Ag/AgCl electrodes placed 
on absorbent cotton containing PBS. After 12 hr, the skin was collected, and 
soaked in 4% PFA for 1 hr at 4 oC. The skin was then soaked in 30% sucrose 
in PBS at 4 oC overnight. The skin was embedded in a freezing block of 
optimal cutting temperature (OCT) compound, and a cross section (10 μm) of 190 
the skin was prepared. Cross sections of skin were washed twice with PBS for 
5 min, and then treated with blocking solution (3% BSA in PBS containing 50 
μl of 0.1% Triton-X) for 1 hr at room temperature. Cross sections were washed 
an additional three times with PBS for 2 min. After washing, cross sections 
were treated with the primary antibody solution containing mouse anti-195 
ceramide IgM (4 μg/ml in 1% BSA-PBS) at 4 oC. After 18 hr of incubation, skin 
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cross sections were washed three times with PBS for 2min., and then 
incubated in a solution of the secondary antibody containing goat anti-mouse 
IgG labeled with Alexa Fluor 488 (4 μg/ml in 1% BSA-PBS) at room temperature 
for 30 min, and washed three-times with PBS for 2 min. Nuclei were stained 200 
by incubating the skin cross sections overnight in the presence of DAPI 
solution, and observed with an LSM700 confocal laser scanning microscope 
(Carl Zeiss, Germany). 
 
2.8. Statistical analysis 205 
Statistical analysis was performed using one-way ANOVA followed by the Tukey–
Kramer honest significant difference (HSD) test. P values <0.05 were considered to be 




3. Results and Discussion 210 
We previously evaluated the uptake of siRNA (MW: ca.12,000), CpG oligo DNA 
(MW: ca. 6,600), in-stem molecular beacon (ISMB) (MW: ca. 12,000), which fluoresces 
upon binding to target mRNA, and an intelligent shRNA expression device (iRed) (MW: 
ca. 200,000) upon treatment with WC (Kigasawa, et al., 2010; Kigasawa, et al., 2011; 
Hasan, et al., 2016a, b). We found that ISMB emitted fluorescence following treatment 215 
of cells with WC, suggesting that macromolecules taken up by WC-mediated endocytosis 
could escape from endosomes (Hasan, et al., 2016b). However, it’s unclear whether the 
macromolecules were taken up during WC treatment.  
We sought to quantitatively evaluate cellular uptake of macromolecules 
following WC treatment. Fluorescent dyes or fluorescence-labeled materials, such as 220 
dextran, are typically used for evaluation of the amount of cellular uptake. However, 
autofluorescence of cells prevents accurate quantification using fluorescence 
measurements. Therefore, PCR measurement of DNA was employed in the present study 
for accurate quantification of WC-mediated cellular uptake. We first used plasmid DNA 
encoding luciferase as a macromolecule for quantification of the amount of cellular 225 
uptake. However, luciferase DNA was not detected by real-time PCR following WC 
treatment (data not shown). It’s possible that the MW of the plasmid DNA (ca. 3,500,000) 
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may have exceeded the size threshold that can be taken up by WC-mediated endocytosis. 
Next, we prepared smaller molecular weight DNA fragment encoding the luciferase open 
reading frame region (MW: ca. 99,000) by PCR using luciferase plasmid DNA as a 230 
template, and exposed the cells to WC treatment in the presence of the DNA fragment. 
Although the DNA fragment was not detected in the cells immediately following WC 
treatment (data not shown), the intracellular amount of the DNA fragment was detected 
at 1 hr after WC treatment, and the amount of the DNA fragment in cells increased 
significantly at 3 hr after WC treatment (Fig. 1). These results suggest that WC can induce 235 
endocytosis. Drug delivery efficiency is generally thought to be related to the current 
intensity of WC. However, we previously optimized the current intensity (0.34 mA/cm2) 
based on in vivo experiments (Kigasawa et al., 2010). Treatment with higher current 
intensity (0.5 mA/cm2) was found to induce inflammation on the surface of the skin. 
Furthermore, we previously found that WC induces de-polymerization of actin 240 
cytoskeleton (Hama et al., 2014). As a result of these effects, cells are easily detached 
from the culture dish upon treatment with higher current intensity in vitro, making it 
difficult to treat cells with higher current intensity (> 0.5 mA/cm2) in an effort to optimize 
endosomal escape efficiency. Therefore, we used the previously identified optimized 
current intensity conditions used in the present study. 245 
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 We then sought to confirm the functionality of high molecular weight proteins 
following delivery to the cytoplasm by WC-mediated endocytosis, since we only 
evaluated the functionalities of nucleic acids in our previous reports (Kigasawa, et al., 
2010; Kigasawa, et al., 2011; Hasan, et al., 2016a, b). In the present study, an antibody 
(MW: ca. 150,000) was used as a representative functional high molecular weight protein 250 
to demonstrate the utility of WC-mediated cytoplasmic delivery. Cells were treated with 
WC in the presence of anti-nuclear pore complex antibody. As the molecular weight of 
this antibody exceeds the size that can leak from endosomes induced by WC, we 
performed WC treatment in the presence of the lysosomotropic agent chloroquine. In our 
previous study, we used chloroquine to enhance the escape of functional nucleic acids, 255 
namely iRed (MW: ca. 200,000), of which molecular weight was over 70,000, from WC-
induced endosomes (Hasan, et al., 2016b). Following WC treatment in the presence of 
the anti-nuclear pore complex antibody with chloroquine, immunohistochemical staining 
of cells was carried out using Alexa Fluor 488-labeled secondary antibody against anti-
nuclear pore complex antibody. The cytotoxicity of chloroquine was evaluated at various 260 
concentrations as a potential side effect. As shown in Supplementary Fig. 1, cell viability 
was not affected by the presence of 10 μM chloroquine. Thus, side effects of chloroquine 
were not observed under the experimental conditions. Using confocal microscopy, we 
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observed green fluorescence at the nuclear membrane, indicating that the anti-nuclear 
pore complex antibody associated with the surface of the nucleus (Fig. 2). These results 265 
suggest that high molecular weight protein antibodies delivered into the cytoplasm by 
WC had escaped from endosomes and exhibited functional binding. Thus, WC treatment 
can be used without carriers to deliver not only nucleic acids but also high molecular 
weight proteins, although supporting materials such as chloroquine may be required for 
effective endosomal escape. 270 
 To confirm the morphological characteristics of endocytosis induced by WC, we 
performed WC treatment in the presence of PEGylated gold nanoparticles (100 nm, -50 
mV), which were used for visualization of macromolecules taken up by WC-mediated 
endocytosis in the present study, and observed the cells after WC treatment by 
transmission electron microscopy (TEM). TEM images showed the presence of several 275 
gold nanoparticles in the endosomes (Figs. 3a1-a3), which exhibited elliptical shapes that 
differed from the spherical shape of typical endosomes, including clathrin-coated 
endosomes (El-Sayed and Harashima, 2013; Sandvig, et al., 2018). Furthermore, we also 
obtained images of the moment that endocytosis occurred following treatment with WC 
(Figs. 3b1-b3). The widths and depths of the endosomes were approximately 100-200 nm 280 
and 500 nm, respectively. Meanwhile, membrane protrusions indicative of the induction 
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of macropinocytosis were not observed, and the sizes of the endosomes were smaller than 
those of macropinosomes (> 1 μm) (El-Sayed and Harashima, 2013). These images 
suggest that WC-mediated endocytosis is not macropinocytosis or clathrin- or caveolae-
dependent endocytosis, although WC-mediated cellular uptake of siRNA was 285 
significantly reduced by inhibitors of macropinocytosis (amiloride) and caveolae-
mediated endocytosis (filipin) as shown in our previous study (Hasan, et al., 2016a). 
Based on previous studies, we speculated that the WC-mediated endocytosis 
observed by TEM (Fig. 3) may be dependent on the GTPase regulator associated with 
focal adhesion kinase-1 (GRAF1) (Hansen and Nichols; 2009; Grant and Donaldson, 290 
2009; El-Sayed and Harashima, 2013), although the endosome width was larger than that 
seen for GRAF1-dependent endocytosis (ca. 40 nm) (Lundmark, et al., 2008). GRAF1-
dependent endocytosis can be inhibited by the amiloride derivative 
ethylisopropylamiloride (EIPA) (El-Sayed and Harashima, 2013). Further, the caveolae 
inhibitor filipin is a cholesterol-binding agent that can inhibit the functionality of lipid 295 
raft membrane domains, which are associated with GRAF1-dependent endocytosis (El-
Sayed and Harashima, 2013). However, WC-mediated cellular uptake of siRNA was not 
inhibited by a high concentration sucrose solution that is known to inhibit clathrin-
dependent endocytosis (Khalil, et al., 2006). Taken together with our previous findings 
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and the results of inhibitor experiments, we hypothesized that WC-mediated endocytosis 300 
is GRAF1-dependent (Hasan, et al., 2016a). 
 Previous studies demonstrated that siRNA knockdown of expression of GRAF1 
and its co-factor Cdc42 could specifically inhibit GRAF1-dependent endocytosis 
(Lundmark, et al., 2008; El-Sayed and Harashima, 2013). Thus, to confirm whether WC-
mediated endocytosis is GRAF1-dependent, we examined the effect of RNAi targeting 305 
GRAF1 and Cdc42 on WC-mediated cellular uptake of the DNA fragment encoding 
luciferase by B16-F1 cells (Fig. 1). Pre-transfection of anti-Cdc42 siRNA or anti-GRAF1 
siRNA reduced the levels of Cdc42 and GRAF1 mRNA in B16-F1 cells to below 30% of 
that seen for non-transfected cells (Supplementary Fig. 2). However, contrary to our 
expectation, the increase in the amount of luciferase-encoding DNA fragment induced by 310 
WC was not reduced by siRNA against either Cdc42 or GRAF1 (Supplementary Fig. 2). 
We also examined the amount of Cdc42 protein, a key factor in GRAF1-dependent 
endocytosis, in cells after WC treatment by western blotting with an anti-Cdc42 antibody. 
Results showed that WC treatment did not affect the amount of Cdc42 protein or Cdc42 
phosphorylation, which inhibits Cdc42 function (Kwon, et al., 2000) (data not shown). 315 
More detailed analysis of the trigger mechanism of WC-mediated endocytosis is required 
in the future.  
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 Next, we focused on the membrane characteristics of WC-induced endosomes, 
which leak macromolecules such as siRNA into the cytoplasm. Previous results suggested 
that WC treatment was responsible for the leakiness of the endosomal membrane. It has 320 
been reported that ceramide can form ceramide channels in the mitochondrial outer 
membrane, and that inter-membrane space proteins (MW: <60,000) are released from the 
mitochondria via ceramide channels (Perera, et al., 2016). Thus, we hypothesized that 
leakiness in the endosomal membrane was caused by localization of ceramide induced by 
WC treatment. To confirm this hypothesis, we examined the intracellular distribution of 325 
ceramide following WC treatment by immunostaining using an anti-ceramide antibody. 
Green fluorescence of anti-ceramide antibody was observed homogeneously in untreated 
cells (Control) (Figs. 4a-1 and 4a-2), which indicates that ceramide is indeed present in 
the cells. On the other hand, strong green fluorescent signals were observed in the 
cytoplasm as dots, which may be due to the presence of vesicular compartments, such as 330 
endosomes (Figs. 4b-1 and 4b-2). The fluorescence intensity of ceramide in each confocal 
laser scanning microscopic image of immuno-stained cells (Fig. 4a and b) was quantified 
using the image analysis software Image J. The difference between WC-treated and 
untreated groups was statistically significant (p<0.01), and the fluorescence intensity of 
the WC-treated group was 1.8-fold higher than that of the untreated group (Fig. 4c). These 335 
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results suggest that localization of ceramide changed from the cytoplasm to endosomes 
upon treatment with WC. Thus, endosomal properties are likely to be altered by 
localization of ceramide following WC treatment; this phenomenon may be responsible 
for the leakiness of WC-induced endosomes. It’s possible that ceramide localized in 
endosomes results in the formation of pores that allow for macromolecules to leak through. 340 
To obtain information regarding WC treatment-induced endocytosis, the 
vesicular compartment in the cells after WC treatment were stained with LysoTracker, 
which can stain acidic compartments such as endosome/lysosomes, after WC treatment 
of B16-F1 cells. As shown in Supplementary Fig. 3(a, b), the intensity of red fluorescence 
derived from LysoTracker was not so potent, and there was no colocalization with green 345 
fluorescence indicating ceramide. Probably, since the ceramide pore would prevent 
acidification by leakage of proton, the WC treatment-induced endosomes could not be 
stained with LysoTracker. Then, we tried to clarify whether the WC treatment-induced 
vesicular compartments are conventional endosomes by immunostaining of the cells after 
WC treatment with antibody against Rab7, which is known as a marker of conventional 350 
endosomes. As shown in Supplementary Fig. 3(c, d), red fluorescent signals of Rab7 did 
not co-localize with green fluorescent signals of ceramide. From this result, it was 
suggested that the ceramide rich vesicular compartments induced by WC treatment would 
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not be the conventional endosomes containing Rab7. Further investigations for 
identification of detail properties and component of ceramide rich vesicular 355 
compartments are required in the future. 
 To confirm whether the same phenomenon is observed in vivo, we performed 
WC treatment of mouse skin and used immunohistochemistry to evaluate the effect of 
WC on the skin distribution of ceramide, which would be a key factor in WC-mediated 
cytoplasmic delivery. As shown in Fig. 5, ceramide fluorescence in the cross section of 360 
the skin treated with WC was greater than that of untreated skin (Fig. 5a and b). In 
addition, the fluorescence intensity of WC-treated skin was 1.86-fold higher than that of 
untreated skin (Fig. 5c). These results confirm that ceramide is increased by WC treatment 
not only in vitro, but also in skin tissue in vivo. As we previously reported that in vivo WC 
treatment of siRNA on the skin showed significant gene knockdown (Kigasawa et al., 365 
2010), macromolecules could be delivered to the cytoplasm by WC treatment even in vivo. 
Thus, results obtained by in vivo immunohistochemistry support the conclusion that 
localization of ceramide causes leakiness of endosomes induced by treatment with WC. 
Furthermore, we examined the in vivo efficacy of WC treatment and cytoplasmic 
delivery of macromolecules using tumor-bearing mice. Regarding cytoplasmic delivery 370 
of macromolecules, we have already published the paper (Kigasawa, et al., 2010). In that 
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paper, we showed the significant mRNA knocking down by iontophoresis (WC treatment 
in vivo) of siRNA in the inflamed skin. The result is the evidence of the cytoplasmic 
delivery of macromolecules siRNA (MW:12,000) by WC in vivo, because the action site 
of siRNA is cytoplasmic space. Thus, significant RNAi effect indicates cytoplasmic 375 
delivery by WC in vivo. WC treatment with anti-glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) siRNA was performed on tumor-bearing mouse skin. As shown 
in Supplementary Fig. 4, mRNA level of GAPDH in tumor was significantly suppressed 
(37%) by WC treatment with anti-GAPDH siRNA. From this result, the WC treatment-
mediated cytoplasmic delivery of macromolecules in vivo was confirmed by using tumor-380 
bearing mice. 
To obtain information regarding the role of ceramide and preferential 
localization of ceramide in WC-induced endosomes, we focused on neutral 
sphingomyelinase 2 and acid sphingomyelinase. Neutral sphingomyelinase 2 has been 
reported to localize to the plasma membrane, Golgi and recycling compartments (Airola, 385 
et al., 2013). On the other hand, acid sphingomyelinase localizes in lysosomes (Jenkins, 
et al., 2009). Thus, we expected that the source of ceramide would be identified by 
inhibition of ceramide synthesis with specific inhibitors against those sphingomyelinases. 
In this study, we used GW4869 and imipramine as specific inhibitors of neutral 
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sphingomyelinase 2 and acid sphingomyelinase, respectively (Airola, et al., 2013; Arenz, 390 
et al., 2010). The relative fluorescence intensity, which indicates the amount of ceramide 
in the cells following WC treatment with a neutral sphingomyelinase inhibitor GW4869, 
was slightly decreased, but the difference was not statistically significant (Supplementary 
Fig. 5a). In contrast, for the acid sphingomyelinase inhibitor imipramine, the amount of 
ceramide did not change (Supplementary Fig. 5b). These results suggest that WC did not 395 
activate ceramide synthesis. WC treatment may increase ceramide in the cells by 
inhibition of degradation or metabolic pathways. However, it was difficult to confirm the 
contribution of degradation/metabolic pathway inhibition in this study. Future studies are 
needed to clarify the mechanism of ceramide increase by WC and obtain direct evidence 
of ceramide pores; that may be responsible for endosomal escape of macromolecules. 400 
The difference in the morphology of WC-induced endosomes from that of other 
endosomes may be the result of WC-induced endocytosis being a type of GRAF1-
dependent tubular endocytosis, although pretreatment with siRNA against GRAF1 and 
cdc42 did not affect WC-mediated cellular uptake (Supplemental Fig. 1). Cellular uptake 
induced by WC treatment was previously shown to be inhibited by amiloride and filipin 405 
(Hasan et al., 2016a). Another possible reason for the tubular morphology of WC-induced 
endosomes may be due to localization of ceramide in the endosomes via WC treatment. 
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However, it is difficult to clarify the exact reason for the tubular morphology of WC-
induced endosomes at this time. 
 In conclusion, we found that WC-mediated endocytosis occurred after treatment 410 
of cells with WC, and that WC treatment can trigger cellular uptake and cytoplasmic 
delivery of exogenous macromolecules. In addition, high molecular weight protein 
antibodies were functional following delivery into the cytoplasm mediated by WC in the 
presence of chloroquine. The WC-induced endosomes, which can leak macromolecules 
(MW: <70,000), exhibited elliptical shapes that differ from those of conventional 415 
endosomes, such as macropinosome, clathrin- or caveolae-dependent endosomes. 
Furthermore, ceramide was found to localize in endosomes following WC treatment. It is 
suggested that localization of ceramide may be cause of the leakiness of the endosomes 
induced by WC. Further investigations are necessary to better elucidate the exact 
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Figure 1. Cellular uptake of DNA fragments after WC treatment. 
The amount of intracellular DNA fragment taken up by B16-F1 cells was measured by 
real-time PCR of samples taken from untreated cells (white column) and those from cells 
taken 1 hr and 3 hr after WC treatment (black columns). Data are mean ± S.D (n=4). 
*p<0.005, vs. 1 hr WC(-) and 3hr WC(-), **p<0.001, vs. 1 hr WC(-), 1 hr WC(+) and 3 520 
hr WC(-). 
 
Figure 2. Immunostaining images of B16-F1 cells after WC treatment in the presence 
of anti-nuclear pore complex protein antibody. 
WC treatment was performed in the presence of anti-nuclear pore complex protein 525 
antibody and chloroquine. After WC treatment, B16-F1 cells were subjected to 
immunostaining with an Alexa Fluor 488-labeled secondary antibody and observed by 
confocal laser scanning microscopy: (a) Alexa Fluor 488-labeled secondary antibody 
(green); (b) transmitted light image; (c) nuclei stained with DAPI (blue), and (d) merged 





Figure 3. Transmission electron microscopy of cells after WC treatment in the 
presence of PEGylated gold nanoparticles. 
B16-F1 cells were fixed 4 hr after WC treatment with gold nanoparticles, and cross-535 
sections of the cells were observed by transmission electron microscopy. Gold 
nanoparticles (100 nm diameter) are indicated by white arrows and the scale bar indicates 
1,000 nm. Panels a-2 and b-2 show magnified images of the square enclosed by dotted 
white lines in a-1 and b-1. Endosomes are indicated by the dotted white lines in a-3 and 
b-3. 540 
 
Figure 4. Immunostaining images of B16-F1 cells using anti-ceramide antibody after 
WC treatment 
After WC treatment, B16-F1 cells were subjected to immunostaining with anti-ceramide 
antibody and an Alexa Fluor 488-labeled secondary antibody, and observed by confocal 545 
laser scanning microscopy: (a) untreated cells (WC(-)) and (b) cells subjected to WC 
treatment (WC(+)). Panels a-2 and b-2 show magnified images of the square enclosed by 
the dotted white lines in a-1 and b-1. Green indicates Alexa Fluor 488-labeled secondary 
antibody and blue indicates nuclei stained with DAPI. The scale bar indicates 20 μm. (c) 
34 
 
Relative intensity of fluorescence of the cells quantified using the image analysis software 550 
Image J. Data are mean ± S.D (n>3). *p<0.01. 
 
Figure 5. Immunohistochemical images of skin cross sections following WC 
treatment using anti-ceramide antibody 
Following WC treatment of mouse skin, cross sections of the skin were subjected to 555 
immunohistochemistry with anti-ceramide antibody and an Alexa Fluor 488-labeled 
secondary antibody, and observed by confocal laser scanning microscopy: (a) untreated 
skin (WC(-)) and (b) skin subjected to WC treatment (WC(+)).Green indicates Alexa 
Fluor 488-labeled secondary antibody and blue indicates nuclei stained with DAPI, 
respectively. The scale bar indicates 20 μm. (c) Relative fluorescence intensity of skin 560 
cross sections quantified using the image analysis software Image J. Data are mean ± S.D 
(n=3). *p<0.05. 
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